TuHURA Biosciences, Inc.
HURA
$2.46
-$0.16-6.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 41.73% | 119.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.22% | 52.67% | |||
| Operating Income | -23.22% | -52.67% | |||
| Income Before Tax | -11.15% | -7.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.15% | -7.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.15% | -7.47% | |||
| EBIT | -23.22% | -52.67% | |||
| EBITDA | -23.35% | -53.55% | |||
| EPS Basic | -8.40% | -65.34% | |||
| Normalized Basic EPS | -8.47% | -93.65% | |||
| EPS Diluted | -8.40% | -65.34% | |||
| Normalized Diluted EPS | -8.47% | -93.65% | |||
| Average Basic Shares Outstanding | 2.55% | -44.58% | |||
| Average Diluted Shares Outstanding | 2.55% | -44.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||